Rajiv Dixit
Rheumatology · Walnut Creek, CANPI 1396748158
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 568 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Amgen at 40.7% of the total. Reporting peaked in 2019 at $3,256 and has fallen 88.7% since, to $367 in 2025.
Across 568 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$5K
- AbbVie$1K
- Johnson & Johnson$884
- Novartis$663
- UCB, Inc.$636
- Pfizer$558
- plus $3K from 24 others
What the payments were for
- Food & beverage$11,98598%
- Education$2282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 225 | $4,972 |
| AbbVie | 47 | $1,313 |
| Johnson & Johnson | 50 | $884 |
| Novartis | 37 | $663 |
| UCB, Inc. | 20 | $636 |
| Pfizer | 32 | $558 |
| Boehringer Ingelheim | 7 | $439 |
| AstraZeneca(2 entities) | 17 | $394 |
| E.r. Squibb & Sons, L.L.C. | 17 | $277 |
| GSK | 15 | $273 |
| Bristol Myers Squibb | 22 | $267 |
| Genentech USA, Inc. | 13 | $247 |
| Aurinia Pharma U.S., Inc. | 8 | $219 |
| Mallinckrodt Enterprises LLC | 14 | $162 |
| Radius Health, Inc. | 6 | $153 |
| Merck | 7 | $123 |
| Sobi, Inc | 5 | $103 |
| Mallinckrodt Hospital Products Inc. | 4 | $81 |
| Lilly USA, LLC | 4 | $68 |
| Medexus Pharma, Inc. | 3 | $66 |
| Sanofi | 3 | $57 |
| ANI Pharmaceuticals, Inc. | 2 | $52 |
| Hikma Pharmaceuticals USA | 3 | $48 |
| Pacira Therapeutics, Inc. | 1 | $37 |
| Oxford Immunotec USA Inc | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Gilead | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Organon | 1 | $19 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,213 in reported general payments places this provider in the 75th percentile of 808 rheumatology providers in California.
Other rheumatology in Walnut Creek
- Anthony PadulaWalnut Creek$536K
- Sudhakar TumuluriSan Francisco$2.8M
- Ara DikranianSan Diego$2.2M
- Orrin TroumSanta Monica$1.8M
- Robin DoreTustin$1.5M
- Samy MetyasCovina$1.3M
- Rhonda LambertSan Mateo$1.1M
- William ShielMission Viejo$924K
- Mark BoriginiDowney$920K
- Adam KreitenbergTarzana$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.